Oraltag

Active Ingredient(s): Iohexol
FDA Approved: * March 26, 2015
Pharm Company: * INTERPHARMA PRAHA AS
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Oraltag Overview

Iohexol, sold under the trade name Omnipaque among others, is a contrast agent used for X-ray imaging.[1] This includes when visualizing arteries, veins, ventricles of the brain, the urinary system, and joints, as well as during computed tomography (CT scan).[1] It is given by mouth, injection into a vein, or into a body cavity.[2] Side effects include vomiting, skin flushing, headache, itchiness, kidney problems, and low blood pressure.[...

Read more Oraltag Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Iohexol

Recent Oraltag Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Iohexol

For Solution: 9.7gm/bot
Injection: 140mgI/ml, 180mgI/ml, 240mgI/ml, 300mgI/ml, 350mgI/ml
Solution: Adults: 1 To 2 Bottles (4.5 G To 9 G Iodine (i)) (2)

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Oraltag: (1 result)

Sorted by National Drug Code

54702-501 Oraltag 4.5 g/1 Oral for Solution by Interpharma Praha, A.s.

Other drugs which contain Iohexol or a similar ingredient: (2 results)

IOHEXOL
OMNIPAQUE Iohexol2 discussions